Snap On Incorporated (SNA) Stock Price Today
Aura AI Summary
Key Stats
- $18.94BMarket Cap
- 327,571Volume
- IndustrialsSector
- $419.3152W High
- $328.6952W Low
- 36 DaysTypical Hold Time
- $18.55BEnterprise Value
- 2.74%Div Yield
- 0% Sell | 100% BuyTrading Activity
Track Snap On Incorporated (SNA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Snap On Incorporated has traded between a low of $328.69 and a high of $419.31, highlighting its annual price range. Buy and sell Snap On Incorporated shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Most Recent News
Paracetamol market to surpass $15B by 2032, led by Asia-Pacific growth and rising demand for pain relief.
The global paracetamol market is projected to grow from $12.05 billion in 2026 to $15.39 billion by 2032, with a CAGR of 4.12%. Growth is driven by increasing demand for pain and fever management, expanded access to over-the-counter medicines, and in...

New Russian-linked cyber tool spies on NATO, EU emails via Microsoft Exchange servers
ESET Research uncovered a sophisticated cyberespionage tool named Cereal, used by the Russia-aligned Turla group to spy on emails within Microsoft Exchange servers of governmental organizations in Kazakhstan and Romania. The tool stealthily collects ...

Trogenix appoints John Young as Chair and Josh Murray as Non-Executive Director to boost global growth and US expansion.
Trogenix, a clinical-stage precision oncology company, has appointed John Young as Chair and Josh Murray as Non-Executive Director to support its global strategy, commercial growth, and US expansion. John Young brings over 35 years of pharmaceutical ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.